Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Cancer Treatment Reports|July 1, 1987
Phase II evaluation of teniposide and ifosfamide in refractory adult acute lymphocytic leukemia: a Southwest Oncology Group StudyD H Ryan, K J Kopecky, D Head, et al.Investigational New Drugs|February 1, 1990
Aclacinomycin A in the treatment of multiple myeloma: a Southwest Oncology Group studyC Karanes, J Crowley, L Sawkar, et al.Bone Marrow Transplantation|November 11, 1999
Cyclophosphamide and paclitaxel as initial or salvage regimen for the mobilization of peripheral blood progenitor cellsJ Klein, P Rey, R Dansey, et al.Bone Marrow Transplantation|February 1, 1994
Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intactL G Lum, I D Joshi, M R Smith, et al.Leukemia|June 24, 2000
Microsatellite instability is not a defining genetic feature of acute myeloid leukemogenesis in adults: results of a retrospective study of 132 patients and review of the literatureL M Rimsza, K J Kopecky, J Ruschulte, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 22, 2001
Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor cell transplantation in the outpatient setting for women with breast cancerP H Chandrasekar, O C Abraham, J Klein, et al.Leukemia Research|March 30, 2000
A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemiaP J Rosen, C Rankin, D R Head, et al.Leukemia & Lymphoma|December 1, 1995
Clinical course and outcome of patients with Hodgkin's disease who progress after autologous transplantationM Varterasian, V Ratanatharathorn, J P Uberti, et al.Bone Marrow Transplantation|June 1, 2000
Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancerJ L Klein, P M Rey, R D Dansey, et al.Blood|April 15, 1993
Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromesV Ratanatharathorn, C Karanes, J Uberti, et al.Pageof 6